Press Releases

TASER Wireless eXtended Range Electronic Projectile (XREP) Successfully Deployed to Save Woman's Life

TASER Wireless eXtended Range Electronic Projectile (XREP) Successfully Deployed to Save Woman's LifeSCOTTSDALE, Ariz., Nov 6, 2009 (GlobeNewswire via COMTEX) -- TASER International, Inc. (Nasdaq:TASR), a market leader in digital evidence solutions and electronic control devices (ECDs), announced that on November 4 the Waukesha Police Department in Wisconsin successfully deployed the TASER® eXtended Range Electronic Projectile (XREP™) from a TASER® X12™ Less Lethal Shotgun (LLS) to subdue a suicidal woman.

According to Waukesha Police, officers responded to a report of a suicidal woman with a knife. She was not only threatening her own life, but the life of another. Upon arrival officers received information that the subject of the call was a 47-year-old woman with a history of mental illness.

Officers located the woman in a highly agitated state. In order to safely take her into protective custody officers deployed the XREP. The deployment was successful and no higher forms of force were needed. Neither the woman nor any officers were injured.

"This is a momentous event for our law enforcement partners as this is the first life protected without injury outside of our pilot programs through the combined use of our production advanced wireless TASER XREP and our TASER X12 Less Lethal Shotgun," said Tom Smith, Chairman and founder of TASER International. "We are pleased with the performance of these two life-saving systems integrating successfully. We applaud the Waukesha Police Department's successful intervention to protect life with TASER technology."


The XREP is a wireless self-contained electronic ECD deployed from a 12-gauge pump-action. It delivers a similar Neuro Muscular Incapacitation (NMI) bio-effect as our handheld TASER® X26™ ECD with a maximum effective range approaching 100 feet (30.48 meters).

The battery supply is fully integrated into the chassis and provides the power to drive the XREP projectile engine and thereby "wireless" compared to traditional hand held TASER ECDs.

While the XREP can be deployed from any 12-gauge pump-action shotgun, Mossberg and TASER International joined forces to produce the TASER® X12™ LLS, utilizing a re-engineered Mossberg 500 pump-action shotgun to optimize the TASER XREP. The TASER X12 includes Radial Key™ Ammunition technology to prevent the system from deploying lethal 12-gauge rounds in order to remove the possibility of end users accidentally firing a lethal round in a less-lethal system during high stress situations.

No other system on the market today prevents the operator from inadvertently deploying a lethal round. In addition, it incorporates a uniquely designed twist, rifled barrel that optimizes the performance of the XREP, ensuring that an optimum spin rate is imparted upon the projectile as it exits the barrel to ensure the greatest distance, stabilization, and accuracy possible.

For more information about the XREP and X12 systems visit:

About TASER International, Inc.

TASER International's products Protect Life and Protect Truth. TASER provides advanced Electronic Control Devices (ECDs) and innovative secured digital evidence collection and management solutions for use in the law enforcement, medical, military, corrections, professional security, and personal safety markets. TASER ECDs use proprietary technology to incapacitate dangerous, combative, or high-risk subjects who pose a risk to law enforcement officers, innocent citizens, or themselves in a manner that is generally recognized as a safer alternative to other uses of force. The TASER® AXON™, a revolutionary on-officer tactical computer and video/audio recorder, combines with an integrated digital multi-media evidence storage and management platform -- EVIDENCE.COM -- to provide an end-to-end solution to capture, store securely, and analyze digital evidence and information in ways that enables tactical and strategic decision making by law enforcement, as well as for legal evidentiary use. For more information please call TASER International at (800) 978-2737 or visit our website at

The TASER International logo is available at

Note to Investors

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such forward-looking statements.

TASER International assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) order delays; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field test results; and (25) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company's Annual Report on Form 10-K and its Form 10-Qs.

The statements made herein are independent statements of TASER International. The inclusion of any third parties does not represent an endorsement of any TASER International products or services by any such third parties.

This news release was distributed by GlobeNewswire,

SOURCE: TASER International, Inc.

CONTACT: TASER International, Inc.
Steve Tuttle, Vice President of Communications
Media ONLY Hotline: (480) 444-4000